Cellbri

CellBri is a biotechnology company specializing in automated cell therapy manufacturing platforms for CAR-T, NK, TCR-T, iPSC, and other advanced therapy types. The company develops closed-system, cGMP-ready modular and all-in-one instruments — including the CellFAB One series — that reduce manual handling, minimize contamination risk, and ensure batch-to-batch repeatability for CDMOs and biopharma developers. Headquartered in Austin, Texas with manufacturing in Shenzhen and Changzhou, China, CellBri's reagent-agnostic, no-proprietary-lock-in philosophy supports over 34 GMP clinical and commercial programs globally.